| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Innovation/ Tech Officer
1 company
Schobel Alexander Mark is a Chief Innovation/ Tech Officer at Aquestive Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 9 sells.
Estimated insider holdings value: $4.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Sell | 50,000 | $6.00 | $300,000.00 | -4.8% | -54.5% | -53.4% | |
| Mar 8, 2024 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Sell | 25,000 | $5.19 | $129,685.00 | -2.3% | -42.4% | -45.7% | |
| Jun 8, 2022 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Buy | 45,871 | $0.96 | $44,036.16 | +5.5% | +38.6% | +138.4% | |
| Feb 10, 2021 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Sell | 35,000 | $6.75 | $236,250.00 | -2.0% | -50.2% | -60.8% | |
| Feb 8, 2021 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Sell | 40,792 | $6.50 | $265,148.00 | -4.5% | -47.6% | -61.0% | |
| May 8, 2020 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Sell | 40,000 | $5.00 | $200,000.00 | -4.2% | - | - | |
| Apr 29, 2020 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Sell | 40,000 | $4.50 | $180,000.00 | -3.8% | - | - | |
| Apr 27, 2020 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Sell | 80,000 | $3.85 | $308,000.00 | -4.0% | - | - | |
| Dec 10, 2018 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Buy | 1,000 | $7.78 | $7,780.00 | - | - | - | |
| Dec 6, 2018 | AQST Aquestive Therapeutics, Inc. | Chief Innovation/ Tech Officer | Buy | 2,000 | $8.69 | $17,380.00 | +0.2% | - | - |